VASN and central nervous system cancer: Elevated levels of vasorin have been demonstrated to bind to and prevent the degradation of Notch1 in glioblastoma, and the resulting augmentation of Notch1 stability is thought to account for the vasorin‐associated aggressiveness of glioma.20